FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis

• Massimo Breccia,
• Giuseppina Loglisci,
• Maria Giovanna Loglisci,
• Roberto Ricci,
• Daniela Diverio,
• Roberto Latagliata,
• Robin Foà,
• Francesco Lo-Coco

Affiliations

Massimo Breccia

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome

Giuseppina Loglisci

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome

Maria Giovanna Loglisci

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome

Roberto Ricci

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome

Daniela Diverio

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome

Roberto Latagliata

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome

Robin Foà

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome

Francesco Lo-Coco

Department of Biopathology, University Tor Vergata, and Laboratory of Neuro-Oncohematology, Santa Lucia Foundation, Rome, Italy